Zobrazeno 1 - 8
of 8
pro vyhledávání: '"35"'
Publikováno v:
Cancer Research. 70:PD09-07
Background: Breast cancer (BCa) is the most common non-cutaneous malignancy and the second leading cause of cancer-related mortality among US women. Obesity has commonly been associated with increased risk for malignancy. There have been few studies
Publikováno v:
Cancer Research. 75:3737-3737
Background: More than one-third of all U.S. adults are obese (BMI >30); and 15% of middle-aged adults, the group most commonly diagnosed and treated for colorectal and other cancers, meet the criteria for class II obesity (BMI> = 35). In contrast to
Autor:
Neel Ingemann Nissen, Christina Jensen, Anders Handrup Kverneland, Marco Donia, Inge Marie Svane, Nicholas Willumsen, Morten A. Karsdal
Publikováno v:
Cancer Research. 81:388-388
Background: Biomarkers for predicting immune checkpoint inhibitor (ICI) efficacy are essential for patient selection for current ICI regimens and new combination therapies. Patients with T-cell excluded tumors have poor effect on ICI therapy. T-cell
Autor:
Sachelly Julián-Serrano, Simran Arjani, Pedro F. Saint-Maurice, Rachael Z. Stolzenberg-Solomon
Publikováno v:
Cancer Research. 81:853-853
Background: Adiposity is associated with pancreatic ductal adenocarcinoma (PDAC), but the effects of weight excess over an adult life course have not been studied extensively. We examined the association between trajectories of body mass index (BMI)
Autor:
Abdoulie Jatta, Gibril Fatty, Saydiba Tamba, Ramou Njie, Yusupha Bah, Sheikh Omar Bittaye, Momodou Musa Sisawo, Lamin Sanneh, Muhammed Tekanyi, Abubacarr Kambi
Publikováno v:
Cancer Research. 80:2346-2346
INTRODUCTION: The clinical manifestations of patients with Hepatocellular carcinoma (HCC) have changed significantly in the last decades in countries that have adopted screening tests. In developing countries due to the rarity of surveillance/screeni
Autor:
Brian Kabat, Jose F. Leis, Wei Ding, Sameer A. Parikh, James R. Cerhan, Aaron D. Norman, Kari G. Chaffee, Daniel R. O'Brien, Timothy G. Call, Susan L. Slager, Neil E. Kay, Geffen Kleinstern, Esteban Braggio
Publikováno v:
Cancer Research. 79:4466-4466
CLL is a clinically heterogeneous disease with wide ranging disease course. A novel CLL-IPI based on Rai/Binet stage, IGHV-mutation status, TP53 mutation/deletion, B2M level, and age was developed to stratify patients into 4 risk groups, with a c-sta
Publikováno v:
Cancer Research. 79:4209-4209
Background: As a tumor suppressor and a factor in glucose metabolism, p53 is an alluring point of focus in the study of obesity and cancer. Population-based studies show that single nucleotide polymorphisms (SNPs) at codon 72 of p53 are individually
Publikováno v:
Cancer Research. 70:904-904
Purpose: Obesity is associated with an increased risk of colon cancer. However, the influence of body mass index (BMI) upon the prognosis of colon cancer survivors and its relationship to gender remains unknown. Experimental Design: BMI (kg/m2) was c